News Breaks |
|
|
| February 15, 2013 |
| 06:12 EDT |  | JNJ | J&J warns doctors outside U.S. to stop Adept hip implants, Bloomberg reports
Johnson & Johnson (JNJ) told doctors outside the U.S. to stop using the company’s Adept hip implant after a higher- than-expected failure rate, reports Bloomberg. A U.K. database found that 12% of patients needed a repeat surgery to fix the implant, which hasn’t been sold since 2011. About 7,500 of the hips were distributed in 21 countries, not including the U.S. Reference Link |
|
|
News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. |
|
|
| May 23, 2013 |
| 10:08 EDT |  | JNJ | On The Fly: Analyst Initiation Summary
 Subscribe for More Information |
|
| 07:31 EDT |  | JNJ | Janssen expects to have more than 25 brand line extensions by 2017
Subscribe for More Information |
|
| 06:29 EDT | | JNJ | Johnson & Johnson coverage assumed with an Underperform at Credit Suisse
Subscribe for More Information |
|
| May 22, 2013 |
| 16:00 EDT |  | JNJ | Options Update; May 22, 2013
Subscribe for More Information |
|
| May 21, 2013 |
| 07:24 EDT |  | JNJ | Global Health Care to host a conference
Subscribe for More Information |
|
| May 17, 2013 |
| 06:19 EDT | | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 10, 2013 |
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 06:16 EDT | | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
|
|
|
|
